抗体
试剂盒
多肽
蛋白
组织芯片
产品中心
Product Center
Research Grade Adalimumab
All
TD-HF879026_1.jpg
TD-HF879026_2.jpg
TD-HF879026_3.jpg
- Catalog： TD-HF879026
- Clonality： mAb
- Application： Research Grade Biosimilar
- Synonyms： ABP501,D2E7,Adalimumab,AdalimumabBeta,CAS:331731-18-1
-
规格：
1mg
-
价格：
¥询价
定制服务咨询
Research Grade Adalimumab
| Catalog No. | TD-HF879026 |
|---|---|
| Species reactivity | Human |
| Applications | Research Grade Biosimilar |
| Host species | Human |
| Isotype | IgG1, kappa |
| Expression system | Mammalian Cells |
| Clonality | Monoclonal |
| Target | TNF, Tumor necrosis factor ligand superfamily member 2, N-terminal fragment, ICD2, NTF, TNF-a, TNF-alpha, Tumor necrosis factor, TNFSF2, TNFA, Cachectin, ICD1 |
| Endotoxin level | Please contact the lab for this information. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Purification | Protein A/G, purified from cell culture supernatant. |
| Accession | P01375 |
| Form | Liquid |
| Storage buffer | 0.01M PBS,pH7.4. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternate Names | ABP501,D2E7,Adalimumab,AdalimumabBeta,CAS:331731-18-1 |
| Background | Adalimumab is a human monoclonal IgG1 antibody targeting tumour necrosis factor α (TNF-α). |
| Note | For research use only. Not for use in clinical or therapeutic applications. |
|
|
SEC-HPLC detection for Research Grade Adalimumab. |
|
|
Detects Human TNFa/TNF-alpha in indirect ELISAs. |
|
|
Flow-cytometry using anti-human TNFa antibody. 293T Transtected cells were stained with an irrelevant antibody (Blue Histogram) or an anti-human TNFa monoclonal antibody (Catalog HF879026, Yellow Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, bound antibody was detected using a a Goat Anti-Human IgG H&L Polyclonal Antibody, FITC (abinScience: HF690414) and cells analysed on a NovoCyte Flow Cytometer. |
|
|
SDS-PAGE for Research Grade Adalimumab. |